Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules

Burak Kürsad Günhan, Paul Meyvisch, Tim Friede

Recently, phase II trials with multiple schedules (frequency of administrations) have become more popular, for instance in the development of treatments for atopic dermatitis. If t…